AI assistant
Sending…
GENTEX CORP — Director's Dealing 2019
Jul 22, 2019
30893_dirs_2019-07-22_c2a7fb0e-c7b9-4a2f-af04-ac6951041c7c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2019-07-22
Reporting Person: SOTOK FREDERICK A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-07-22 | Common Stock | M | 7000.00 | $18.70 | Acquired | 39099.00 | Direct |
| 2019-07-22 | Common Stock | M | 3000.00 | $15.74 | Acquired | 42099.00 | Direct |
| 2019-07-22 | Common Stock | S | 10000.00 | $26.3541 | Disposed | 32099.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-07-22 | Employee Stock Option (Right to buy) | $18.70 | M | 7000.00 | Disposed | 2027-05-18 | Common Stock (7000.00) | Direct |
| 2019-07-22 | Employee Stock Option (Right to buy) | $15.74 | M | 3000.00 | Disposed | 2026-05-19 | Common Stock (3000.00) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $26.32 to $26.38. The price reported above reflects the weighted average price.
F2: Options are fully vested.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19